These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 31835271)

  • 1. Maternal serum levels of perfluoroalkyl substances in early pregnancy and offspring birth weight.
    Wikström S; Lin PI; Lindh CH; Shu H; Bornehag CG
    Pediatr Res; 2020 May; 87(6):1093-1099. PubMed ID: 31835271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children.
    Skogheim TS; Villanger GD; Weyde KVF; Engel SM; Surén P; Øie MG; Skogan AH; Biele G; Zeiner P; Øvergaard KR; Haug LS; Sabaredzovic A; Aase H
    Int J Hyg Environ Health; 2020 Jan; 223(1):80-92. PubMed ID: 31653559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal plasma concentrations of perfluoroalkyl and polyfluoroalkyl substances during pregnancy and anogenital distance in male infants.
    Tian Y; Liang H; Miao M; Yang F; Ji H; Cao W; Liu X; Zhang X; Chen A; Xiao H; Hu H; Yuan W
    Hum Reprod; 2019 Jul; 34(7):1356-1368. PubMed ID: 31242507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of perfluoroalkyl substances in cord serum and association with growth indicators in newborns from Beijing.
    Shi Y; Yang L; Li J; Lai J; Wang Y; Zhao Y; Wu Y
    Chemosphere; 2017 Feb; 169():396-402. PubMed ID: 27886542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of seven perfluoroalkyl and polyfluoroalkyl substances in serum of pregnant women and evaluation of neonatal neurobehavior based on high performance liquid chromatography-tandem mass spectrometry].
    Wang ZH; Liang FZ; Chen XR; Wu P; Wu W
    Se Pu; 2024 Feb; 42(2):194-202. PubMed ID: 38374600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal trends of perfluoroalkyl acids in plasma samples of pregnant women in Hokkaido, Japan, 2003-2011.
    Okada E; Kashino I; Matsuura H; Sasaki S; Miyashita C; Yamamoto J; Ikeno T; Ito YM; Matsumura T; Tamakoshi A; Kishi R
    Environ Int; 2013 Oct; 60():89-96. PubMed ID: 24013022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association of Prenatal Exposure to Perfluorinated Chemicals with Maternal Essential and Long-Chain Polyunsaturated Fatty Acids during Pregnancy and the Birth Weight of Their Offspring: The Hokkaido Study.
    Kishi R; Nakajima T; Goudarzi H; Kobayashi S; Sasaki S; Okada E; Miyashita C; Itoh S; Araki A; Ikeno T; Iwasaki Y; Nakazawa H
    Environ Health Perspect; 2015 Oct; 123(10):1038-45. PubMed ID: 25840032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal exposure to perfluoroalkyl chemicals and anogenital distance in the offspring: A Faroese cohort study.
    Christensen JVR; Bangash KK; Weihe P; Grandjean P; Nielsen F; Jensen TK; Petersen MS
    Reprod Toxicol; 2021 Sep; 104():52-57. PubMed ID: 34182087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between perfluorinated compound concentrations in cord serum and birth weight using multiple regression models.
    Lee ES; Han S; Oh JE
    Reprod Toxicol; 2016 Jan; 59():53-9. PubMed ID: 26562669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Costa O; Santa-Marina L; Pereda-Pereda E; Schettgen T; Sunyer J; Vrijheid M
    Environ Int; 2017 Nov; 108():278-284. PubMed ID: 28917208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal exposure to perfluoroalkyl substances and thyroid hormone concentrations in cord plasma in a Chinese birth cohort.
    Liang H; Wang Z; Miao M; Tian Y; Zhou Y; Wen S; Chen Y; Sun X; Yuan W
    Environ Health; 2020 Nov; 19(1):127. PubMed ID: 33243245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal exposure to perfluoroalkyl substances and adipocytokines: the HOME Study.
    Buck CO; Eliot MN; Kelsey KT; Calafat AM; Chen A; Ehrlich S; Lanphear BP; Braun JM
    Pediatr Res; 2018 Dec; 84(6):854-860. PubMed ID: 30250302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated measurements of per- and polyfluoroalkyl substances (PFASs) from 1979 to 2007 in males from Northern Norway: assessing time trends, compound correlations and relations to age/birth cohort.
    Nøst TH; Vestergren R; Berg V; Nieboer E; Odland JØ; Sandanger TM
    Environ Int; 2014 Jun; 67():43-53. PubMed ID: 24657493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal exposure to 11 perfluoroalkyl substances and fetal growth: A large-scale, prospective birth cohort study.
    Kashino I; Sasaki S; Okada E; Matsuura H; Goudarzi H; Miyashita C; Okada E; Ito YM; Araki A; Kishi R
    Environ Int; 2020 Mar; 136():105355. PubMed ID: 32029284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal exposure to perfluoroalkyl substances, immune-related outcomes, and lung function in children from a Spanish birth cohort study.
    Manzano-Salgado CB; Granum B; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Gascón M; Martínez D; Guxens M; Basterretxea M; Zabaleta C; Schettgen T; Sunyer J; Vrijheid M; Casas M
    Int J Hyg Environ Health; 2019 Jul; 222(6):945-954. PubMed ID: 31262703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral difficulties in 7-year old children in relation to developmental exposure to perfluorinated alkyl substances.
    Oulhote Y; Steuerwald U; Debes F; Weihe P; Grandjean P
    Environ Int; 2016 Dec; 97():237-245. PubMed ID: 27692925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and childhood atopic dermatitis: a prospective birth cohort study.
    Chen Q; Huang R; Hua L; Guo Y; Huang L; Zhao Y; Wang X; Zhang J
    Environ Health; 2018 Jan; 17(1):8. PubMed ID: 29343261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study.
    Starling AP; Engel SM; Whitworth KW; Richardson DB; Stuebe AM; Daniels JL; Haug LS; Eggesbø M; Becher G; Sabaredzovic A; Thomsen C; Wilson RE; Travlos GS; Hoppin JA; Baird DD; Longnecker MP
    Environ Int; 2014 Jan; 62():104-12. PubMed ID: 24189199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in British girls.
    Maisonet M; Terrell ML; McGeehin MA; Christensen KY; Holmes A; Calafat AM; Marcus M
    Environ Health Perspect; 2012 Oct; 120(10):1432-7. PubMed ID: 22935244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Life Exposures to Perfluoroalkyl Substances in Relation to Adipokine Hormone Levels at Birth and During Childhood.
    Shelly C; Grandjean P; Oulhote Y; Plomgaard P; Frikke-Schmidt R; Nielsen F; Zmirou-Navier D; Weihe P; Valvi D
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5338-5348. PubMed ID: 31216000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.